GRAL Net Income Growth
11.60%TTM
Period ending:
GRAL TTM Net Income YoY %%
100.58%-74.89%
2024-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
GRAL net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 7 observations from Dec 31, 2024 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 11.5961% | |
| 79.3489% | |
| 79.8545% | |
| 79.0103% | |
| 83.6016% | |
| -46.2529% | |
| -57.9092% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All GRAL financial metrics · GRAL stock overview · How to interpret financial metrics
